<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00151658</url>
  </required_header>
  <id_info>
    <org_study_id>SCANDSTENT</org_study_id>
    <nct_id>NCT00151658</nct_id>
  </id_info>
  <brief_title>Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)</brief_title>
  <official_title>Randomized Multicenter Comparison of Sirolimus Versus Bare Metal Stent Implantation in Complex Coronary Lesions. Acronym: Scand Stent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the clinical and angiographic outcome of&#xD;
      implantation of stents eluting or not eluting Sirolimus in patients with complex coronary&#xD;
      artery lesions suitable for percutaneous coronary intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2002</start_date>
  <completion_date>June 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Minimal lumen diameter</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of restenosis (&gt;50%) at 6 months.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diameter stenosis, late loss and loss index at 6 months MACE: death, myocardial infarction, target lesion revascularisation within 12 months and 24 months</measure>
  </secondary_outcome>
  <enrollment>322</enrollment>
  <condition>Ischaemic Heart Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coronary Drug Eluting Stents for PCI</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Stable, or unstable angina and/or objective signs of myocardial ischaemia Lesions should be&#xD;
        de novo and located in native vessels with a diameter &gt; 2.25 mm.&#xD;
&#xD;
        Complex lesions to be included should have at least one of the following characteristics:&#xD;
&#xD;
          -  Ostial in location (&lt; 5 mm from ostium)&#xD;
&#xD;
          -  Total occlusions with a length ≥ 15 mm&#xD;
&#xD;
          -  Bifurcational (side branch &gt; 1.75 mm in diameter)&#xD;
&#xD;
          -  Angulated (&gt; 45° within lesion)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  Other severe disease with an expected survival &lt; 1 year&#xD;
&#xD;
          -  Other significant cardiac disease&#xD;
&#xD;
          -  Known allergy against paclitaxel, clopidogrel or stainless steel.&#xD;
&#xD;
          -  Myocardial infarction within 3 days of the index procedure&#xD;
&#xD;
          -  Linguistic difficulties needing an interpreter&#xD;
&#xD;
          -  Renal insufficiency (p-creatinine &gt; 200 micromol/l)&#xD;
&#xD;
          -  Gastrointestinal bleeding within 1 month&#xD;
&#xD;
          -  Childbearing potential or pregnancy&#xD;
&#xD;
          -  Participation in another study&#xD;
&#xD;
        Lesions:&#xD;
&#xD;
          -  Unprotected left main disease&#xD;
&#xD;
          -  Restenosis&#xD;
&#xD;
          -  Lesions containing visible thrombus&#xD;
&#xD;
          -  Treatment with other modality than balloon or stent (ablation, brachytherapy,&#xD;
             ultrasound) in connection with the index procedure&#xD;
&#xD;
          -  Diffuse coronary disease distal to the treated lesion&#xD;
&#xD;
          -  Heavily calcification&#xD;
&#xD;
          -  Lesion located in saphenous vein graft&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henning Kelbaek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2005</study_first_posted>
  <last_update_submitted>September 12, 2005</last_update_submitted>
  <last_update_submitted_qc>September 12, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2005</last_update_posted>
  <keyword>Coronary complex lesions</keyword>
  <keyword>Restenosis</keyword>
  <keyword>Drug eluting stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

